Webcast CME

How to Obtain AMA PRA Category 1 Credit

  1. Complete the Activity.
  2. Complete the CME posttest (each question must be answered correctly).
  3. Log into your myCME account.
  4. Complete the credit and evaluation form.
  5. Print your personalized CME certificate.
  6. Credit can only be claimed once for this activity.

Technical Requirements

Biologic Therapies VI: Optimizing Therapies

Biosimilars Part 1: History and Biology

Print this Content

Release Date: July 8, 2015
Expiration Date: July 8, 2017

Estimated Time of Completion:   15 minutes

Description

Biologic Therapies VI: Optimizing Therapies online series features an international, multi-disciplinary faculty of experts critically appraise recent basic laboratory breakthroughs in terms of their potential clinical implications and provide in-depth analyses of approved agents, new agents, predicting toxicity, clinical controversies, and new indications.

Biosimilars Part 1: History and Biology webcast identifies biosimilarity and biomimics.

Learning Objectives

  1. Define biosimilarity, as specified by regulatory agencies.
  2. Differentiate biomimics (intended copies) from biosimilars.
  3. Describe the consequences of changes in manufacture of originator biopharmaceuticals.

Target Audience

The online series is designed for rheumatologists, dermatologists, gastroenterologists, internal medicine physicians, oncologists, and associated allied health practitioners, including nurse practitioners, nurses, physician assistants interested in or using biologic therapeutics for autoimmune and inflammatory disorders.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Director and Faculty

Activity Directors

Leonard Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Theodore F. Classen DO Chair of Osteopathic Research and Education
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

M. Elaine Husni, MD, MPH
Director, Arthritis and Musculoskeletal Treatment Center
Vice Chair, Department of Rheumatic & Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Faculty

Jonathan Kay, MD
Professor of Medicine
University of Massachusetts Medical School
Director of Clinical Research
Division of Rheumatology
UMass Memorial Medical Center
Worcester, MA

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship which, in the context of their contribution, could be perceived as a potential conflict of interest:

Leonard Calabrese, DO
  Abbvie, Inc.; Bristol Myers Squibb; Genentech/Roche; Janssen Scientific Affairs, LLC Consulting; Teaching and Speaking
  Crescendo Bioscience, Inc. Teaching and Speaking
  GSK; Pfizer; Inc., Sanofi Aventis; UCB, Inc. Consulting
 
Jonathan Kay, MD
  Abbvie, Inc.; Lilly; Pfizer, Inc. Consulting; Independent contractor (including contracted research)
  Alexion; Samsung Bioepis Membership on advisory committee or review panels
  Amgen; Astra Zeneca; Boehringer Ingelheim; Bristol-Myers Squibb Co.; Crescendo Bioscience, Inc.; Epirus Biopharaceuticals; Genentech; Hospira; Janssen; PanGenetics, B.V.; UCB Consulting
  Ardea Independent contractor (including contracted research)
  Roche Pharmaceuticals Independent contractor (including contracted research); Membership on advisory committee or review panels

The following faculty has indicated she has no relationship which, in the context of her presentation, could be perceived as a potential conflict of interest:

M. Elaine Husni, MD, MPH

The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this activity from:

Abbvie, Inc.
Bristol-Myers Squibb
Celgene Corporation
Crescendo Bioscience Inc.
Genentech, Inc.
Janssen Scientific Affairs, LLC
Pfizer
Questcor Pharmaceuticals, Inc.
UCB, Inc.

This CME activity was produced by Cleveland Clinic Foundation Center for Continuing Education and R.J. Fasenmyer Center for Clinical Immunology.